92 related articles for article (PubMed ID: 3166364)
1. Synthesis and biological properties of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid.
Boschelli DH; Webber S; Whiteley JM; Oronsky AL; Kerwar SS
Arch Biochem Biophys; 1988 Aug; 265(1):43-9. PubMed ID: 3166364
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antifolate activity of 5-methyl-5,10-dideaza analogues of aminopterin and folic acid and an alternative synthesis of 5,10-dideazatetrahydrofolic acid, a potent inhibitor of glycinamide ribonucleotide formyltransferase.
Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Thorndike J; Sirotnak FM
J Med Chem; 1988 Nov; 31(11):2164-9. PubMed ID: 3184124
[TBL] [Abstract][Full Text] [Related]
3. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM; McGuire JJ
Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of 7-oxo substituted analogues of 5-deaza-5,6,7,8-tetrahydrofolic acid (5-DATHF) and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF).
Borrell JI; Teixidó J; Matallana JL; Martínez-Teipel B; Colominas C; Costa M; Balcells M; Schuler E; Castillo MJ
J Med Chem; 2001 Jul; 44(14):2366-9. PubMed ID: 11428931
[TBL] [Abstract][Full Text] [Related]
5. Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors.
Ferguson K; Boschelli D; Hoffman P; Oronsky A; Whiteley J; Webber S; Galivan J; Freishiem J; Hynes J; Kerwar SS
Cancer Chemother Pharmacol; 1989; 25(3):173-6. PubMed ID: 2598407
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of 5-deaza-5,6,7,8-tetrahydrofolic acid and its N10-substituted analogues.
Taylor EC; Hamby JM; Shih C; Grindey GB; Rinzel SM; Beardsley GP; Moran RG
J Med Chem; 1989 Jul; 32(7):1517-22. PubMed ID: 2738886
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antifolate properties of 10-alkyl-5,10-dideaza analogues of methotrexate and tetrahydrofolic acid.
DeGraw JI; Christie PH; Kisliuk RL; Gaumont Y; Sirotnak FM
J Med Chem; 1990 Feb; 33(2):673-7. PubMed ID: 2299633
[TBL] [Abstract][Full Text] [Related]
8. A simplified and efficient synthesis of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF).
Taylor EC; Chaudhari R; Lee K
Invest New Drugs; 1996; 14(3):281-5. PubMed ID: 8958183
[TBL] [Abstract][Full Text] [Related]
9. Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane-transport characteristics for (anti)folate compounds.
Jansen G; Westerhof GR; Kathmann I; Rijksen G; Schornagel JH
Cancer Chemother Pharmacol; 1991; 28(2):115-7. PubMed ID: 2060081
[TBL] [Abstract][Full Text] [Related]
10. Determinants of the disparate antitumor effects of (6R)5,10-dideaza-5,6,7,8- tetrahydrofolate and methotrexate toward methotrexate resistant CCRF-CEM cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM
Adv Exp Med Biol; 1993; 338():783-6. PubMed ID: 8304229
[No Abstract] [Full Text] [Related]
11. Synthesis and biological activity of acyclic analogues of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid.
Shih C; Gossett LS; Worzalla JF; Rinzel SM; Grindey GB; Harrington PM; Taylor EC
J Med Chem; 1992 Mar; 35(6):1109-16. PubMed ID: 1552503
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of 4-amino-7-oxo-substituted analogues of 5-deaza-5,6,7,8-tetrahydrofolic acid and 5,10-dideaza-5, 6,7,8-tetrahydrofolic acid.
Borrell JI; Teixidó J; Martínez-Teipel B; Matallana JL; Copete MT; Llimargas A; García E
J Med Chem; 1998 Aug; 41(18):3539-45. PubMed ID: 9719607
[TBL] [Abstract][Full Text] [Related]
13. Thienyl and thiazolyl acyclic analogues of 5-deazatetrahydrofolic acid.
Hodson SJ; Bigham EC; Duch DS; Smith GK; Ferone R
J Med Chem; 1994 Jun; 37(13):2112-5. PubMed ID: 8027993
[TBL] [Abstract][Full Text] [Related]
14. 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines.
Pizzorno G; Cashmore AR; Moroson BA; Cross AD; Smith AK; Marling-Cason M; Kamen BA; Beardsley GP
J Biol Chem; 1993 Jan; 268(2):1017-23. PubMed ID: 8419310
[TBL] [Abstract][Full Text] [Related]
15. A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis.
Beardsley GP; Moroson BA; Taylor EC; Moran RG
J Biol Chem; 1989 Jan; 264(1):328-33. PubMed ID: 2909524
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
Zhao R; Gao F; Babani S; Goldman ID
Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 5-deazaisofolic acid, 5-deaza-5,6,7,8-tetrahydroisofolic acid, and their N9-substituted analogues.
Singh SK; Dev IK; Duch DS; Ferone R; Smith GK; Freisheim JH; Hynes JB
J Med Chem; 1991 Feb; 34(2):606-10. PubMed ID: 1995883
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
Mini E; Moroson BA; Franco CT; Bertino JR
Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate.
Li WW; Tong WP; Bertino JR
Clin Cancer Res; 1995 Jun; 1(6):631-6. PubMed ID: 9816025
[TBL] [Abstract][Full Text] [Related]
20. 5,10-Dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF): a potent inhibitor of purine biosynthesis.
Nutr Rev; 1990 Nov; 48(11):421-3. PubMed ID: 2080047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
